SCHEMBL9208908

SCHEMBL9208908

O=C1C=c2c(Cc3ccncc3)ccnc2=N1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.35
CYP11B2 P19099 5/20 0.35
CYP17A1 P05093 4/20 0.35
CYP19A1 P11511 3/20 0.35
PLA2G7 Q13093 2/20 0.34
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
PNP P00491 1/20 0.33
POLB P06746 1/20 0.33
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.30
HRH4 Q9H3N8 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
KCNH2 Q12809 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9218850 0.98 CYP11B1 (0.35) CYP11B1CYP11B2CYP17A1CYP19A1PLA2G7
SCHEMBL9208904 0.64 CYP3A4 (0.34) CYP11B1CYP11B2CYP17A1CYP19A1PLA2G7
Hydrochloric Acid SCHEMBL9218848 0.62 CYP3A4 (0.33) CYP11B1CYP11B2CYP17A1CYP19A1PLA2G7
SCHEMBL9694376 0.62 CYP17A1 (0.44) CYP11B1CYP11B2CYP17A1CYP19A1PNP
SCHEMBL721736 0.61 CYP17A1 (0.61) CYP11B1CYP11B2CYP17A1CYP19A1POLB
SCHEMBL4976694 0.59 CYP17A1 (0.46) CYP11B1CYP11B2CYP17A1CYP19A1PNP
SCHEMBL13873567 0.59 CYP17A1 (0.65) CYP11B1CYP11B2CYP17A1CYP19A1POLB
SCHEMBL14257671 0.56 CYP17A1 (0.54) CYP11B1CYP11B2CYP17A1CYP19A1POLB
SCHEMBL27884901 0.56 MAOA (0.67) CYP11B1CYP11B2CYP17A1CYP19A1POLB
SCHEMBL17737242 0.56 KMT2A (0.44) CYP11B1CYP11B2CYP17A1CYP19A1PLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0660833-A1 3,3'-DISUBSTITUTED-1,3-DIHYDRO-2H-PYRROLO 2,3-b]HETEROCYCLIC-2-ONE USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS OF MAN THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-07-05 EP disclosed